The Readout Loud

262: Merck v. USA, the best of ASCO, and Leqembi at the FDA


Listen Later

STAT Washington correspondent Rachel Cohrs joins us to explain Merck's lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion." We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.
...more
View all episodesView all episodes
Download on the App Store

The Readout LoudBy STAT

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

304 ratings


More shows like The Readout Loud

View all
Planet Money by NPR

Planet Money

30,845 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,040 Listeners

Odd Lots by Bloomberg

Odd Lots

1,789 Listeners

KFF Health News' 'What the Health?' by KFF Health News

KFF Health News' 'What the Health?'

478 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

Talks at GS by Goldman Sachs

Talks at GS

84 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,942 Listeners

Tradeoffs by Tradeoffs

Tradeoffs

391 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

59 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

29 Listeners

Hard Fork by The New York Times

Hard Fork

5,462 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

147 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

Ground Truths by Eric Topol

Ground Truths

51 Listeners

Money Stuff: The Podcast by Bloomberg

Money Stuff: The Podcast

371 Listeners